Search Results - "Jarolím, P"

Refine Results
  1. 1

    Multicenter analytical evaluation of a high-sensitivity troponin T assay by Saenger, A.K., Beyrau, R., Braun, S., Cooray, R., Dolci, A., Freidank, H., Giannitsis, E., Gustafson, S., Handy, B., Katus, H., Melanson, S.E., Panteghini, M., Venge, P., Zorn, M., Jarolim, P., Bruton, D., Jarausch, J., Jaffe, A.S.

    Published in Clinica chimica acta (11-04-2011)
    “…High-sensitivity cardiac troponin assays are being introduced clinically for earlier diagnosis of acute myocardial infarction (AMI). We evaluated the…”
    Get full text
    Journal Article
  2. 2

    Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 by Sabatine, Marc S., Morrow, David A., de Lemos, James A., Jarolim, Petr, Braunwald, Eugene

    Published in European heart journal (01-01-2009)
    “…Aims To determine whether an ultrasensitive assay can permit quantification of changes in circulating cardiac troponin (Tn) in the setting of stress…”
    Get full text
    Journal Article
  3. 3

    Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial by Foster, M. C., Weiner, D. E., Bostom, A. G., Carpenter, M. A., Inker, L. A., Jarolim, P., Joseph, A. A., Kusek, J. W., Pesavento, T., Pfeffer, M. A., Rao, M., Solomon, S. D., Levey, A. S.

    Published in American journal of transplantation (01-09-2017)
    “…Cystatin C and beta‐2‐microglobulin (B2M) are filtration markers associated with adverse outcomes in nontransplant populations, sometimes with stronger…”
    Get full text
    Journal Article
  4. 4

    The dynamics of gene expression in human lung microvascular endothelial cells after stimulation with inflammatory cytokines by Zachlederová, M, Jarolím, P

    Published in Physiological research (2006)
    “…Vascular endothelium plays an essential role in the pathogenesis of vasoocclusion. The changes in the endothelial cell function can be triggered by changes in…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Incomplete distal renal tubular acidosis coinherited with a mutation in the band 3 (AE1) gene by Rysavá, R, Tesar, V, Jirsa, Jr, M, Brabec, V, Jarolím, P

    Published in Nephrology, dialysis, transplantation (01-09-1997)
    “…Band 3 (anion exchanger 1, AE1) is one of the most abundant proteins of the erythrocyte membrane. We have previously characterized twenty AE1 gene defects…”
    Get full text
    Journal Article
  7. 7

    Combination of two mutant alpha spectrin alleles underlies a severe spherocytic hemolytic anemia by Wichterle, H, Hanspal, M, Palek, J, Jarolim, P

    Published in The Journal of clinical investigation (15-11-1996)
    “…We studied a patient with a severe spherocytic hemolytic anemia without family history of spherocytosis. Analysis of patient's erythrocyte membrane proteins…”
    Get full text
    Journal Article
  8. 8

    Transpulmonary proteome gradients identify inflammatory pathways involved in the development of pulmonary vasculopathy in heart failure by Melenovsky, V, Jarolim, P, Kutilkova, E, Jenca, D, Binova, J, Benes, J, Al-Hiti, H, Miklovic, M, Borlaug, B A

    Published in European heart journal (28-10-2024)
    “…Abstract Background Some, but not all, patients with heart failure (HF) develop pulmonary vascular disease (PVD), which contributes to poor prognosis…”
    Get full text
    Journal Article
  9. 9

    Characterization of Seven Low Incidence Blood Group Antigens Carried by Erythrocyte Band 3 Protein by Jarolim, P., Rubin, H.L., Zakova, D., Storry, J., Reid, M.E.

    Published in Blood (15-12-1998)
    “…Recent studies have demonstrated that band 3 carries antigens of the Diego blood group system and have elucidated the molecular basis of several previously…”
    Get full text
    Journal Article
  10. 10

    Circulating beta-hydroxybutyrate levels in advanced HFrEF: the determinants and prognostic impact by Melenovsky, V, Benes, J, Monzo, L, Kotrc, M, Reichenbach, A, Jurcova, I, Kovar, J, Jarolim, P, Kautzner, J

    Published in European heart journal (09-11-2023)
    “…Abstract Background Beta-hydroxybutyrate (BOHB) is the main ketone body and is generated mainly in the liver during states of exessive fatty acid (FA)…”
    Get full text
    Journal Article
  11. 11

    Deletion in Erythrocyte Band 3 Gene in Malaria-Resistant Southeast Asian Ovalocytosis by Jarolim, P, Palek, J, Amato, D, Hassan, K, Sapak, P, Nurse, G T, Rubin, H L, Zhai, S, Sahr, K E, Liu, S C

    “…Southeast Asian ovalocytosis (SAO) is a hereditary condition that is widespread in parts of Southeast Asia. The ovalocytic erythrocytes are rigid and resistant…”
    Get full text
    Journal Article
  12. 12

    Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency by HASSOUN, H, VASSILIADIS, J. N, MURRAY, J, NJOLSTAD, P. R, ROGUS, J. J, BALLAS, S. K, SCHAFFER, F, JAROLIM, P, BRABEC, V, PALEK, J

    Published in Blood (01-07-1997)
    “…Several subsets of patients with hereditary spherocytosis (HS) have been defined based on the specific red blood cell membrane protein deficiencies involving…”
    Get full text
    Journal Article
  13. 13

    Lipoprotein(a) and the risk of major adverse limb events in patients with stable atherosclerotic vascular disease by Bonaca, M, Morrow, D A, Giugliano, R P, Scirica, B M, Palazzolo, M G, Jarolim, P, Creager, M A, O'donoghue, M, Sabatine, M S

    Published in European heart journal (09-11-2023)
    “…Abstract Background/Introduction Patients with atherosclerotic vascular disease are at heightened risk of ischemic events, including adverse limb events. The…”
    Get full text
    Journal Article
  14. 14

    Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study by Haller, P M, Jarolim, P, Palazzolo, M, Bellavia, A, Harrington, J, Healey, J S, Connolly, S J, Eikelboom, J, Granger, C B, Patel, M R, Ruff, C T, Wallentin, L, Giugliano, R P, Morrow, D A

    Published in European heart journal (28-10-2024)
    “…Abstract Introduction Heart failure (HF) is one of the most common comorbidities in patients with AF, resulting in a clinical need for robust risk assessment…”
    Get full text
    Journal Article
  15. 15

    Mutations of Conserved Arginines in the Membrane Domain of Erythroid Band 3 Lead to a Decrease in Membrane-Associated Band 3 and to the Phenotype of Hereditary Spherocytosis by Jarolim, Petr, Rubin, Hillard L., Brabec, Vaclav, Chrobak, Ladislav, Zolotarev, Alexander S., Alper, Seth L., Brugnara, Carlo, Wichterle, Hynek, Palek, Jiri

    Published in Blood (01-02-1995)
    “…To elucidate the molecular basis of band 3 deficiency in a recently defined subset of patients with autosomal dominant hereditary spherocytosis (HS), we…”
    Get full text
    Journal Article
  16. 16

    Lipoprotein(a), cardiovascular events, and benefit of P2Y12 inhibition: insights from the PEGASUS-TIMI 54 trial by Patel, S, Morrow, D, Bonaca, M, Palazzolo, M, Jarolim, P, Steg, P G, Bhatt, D, Storey, R, Cohen, M, Braunwald, E, Sabatine, M, O'Donoghue, M

    Published in European heart journal (03-10-2022)
    “…Abstract Background Lp(a) plays a causal role in atherogenesis and may exert pro-thrombotic effects by inhibiting fibrinolysis owing to its structural homology…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Interleukin-6 predicts recovery of systolic function after myocardial infarction by Jenca, D, Jarolim, P, Melenovsky, V, Mrazkova, J, Sramko, M, Zelizko, M, Kotrc, M, Franekova, J, Viczenova, D, Adamkova, V, Kautzner, J, Wohlfahrt, P

    Published in European journal of preventive cardiology (11-05-2022)
    “…Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): Ministry of Health of the Czech…”
    Get full text
    Journal Article
  20. 20